chronic wound
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) the subject voluntarily signs the informed consent for this study; 2) over 18 years of age, regardless of gender; 3) acute and chronic infection wounds, with signs of infection, in line with the clinical diagnosis of infection 4) patients whose skin defect area is too large and need to be treated with grafts or flaps at a later stage; 5) the subject can follow the drug dose and visit plan; 6) subjects can follow the intervention plan and visit plan;
Exclusion criteria
Exclusion criteria: 1) exposure of vital organs; 2) incomplete debridement of the wound; 3) untreated osteomyelitis or sepsis exists in the wound; 4) untreated coagulation dysfunction; 5) scab-covered wounds of necrotic tissue; 6) malignant tumor wound; 7) those who are allergic to the sealing film. 8) patients who have participated in other clinical trials within 3 months before the trial (including the intervention measures in this trial); 9) sponsors directly participating in the trial or study their family members; 10) the researchers considered that there was no reason to be included.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| skin flap survival; | — |
Countries
China
Contacts
Eastern Theater General Hospital